Health and Fitness Health and Fitness
Mon, September 17, 2012
Sun, September 16, 2012
Fri, September 14, 2012
Thu, September 13, 2012
Wed, September 12, 2012
Tue, September 11, 2012
Mon, September 10, 2012
Sun, September 9, 2012
Fri, September 7, 2012
Thu, September 6, 2012
Wed, September 5, 2012
Tue, September 4, 2012
Mon, September 3, 2012
Sun, September 2, 2012
Sat, September 1, 2012
Fri, August 31, 2012
Thu, August 30, 2012

Synta to Present at Upcoming September Investor Conferences


//health-fitness.news-articles.net/content/2012/ .. -at-upcoming-september-investor-conferences.html
Published in Health and Fitness on Thursday, September 6th 2012 at 5:37 GMT by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the following September investor conferences:

[ Rodman & Renshaw Annual Global Investment Conference ] in New York
Monday, September 10 at 1:35 p.m. (ET)

[ ThinkEquityas 9th Annual Growth Conference ] in New York
Wednesday, September 12 at 3:30 p.m. (ET)

[ UBS Global Life Sciences Conference ] in New York
Thursday, September 20, 2012 at 3:30 p.m. (ET)

Noble Financial Markets Life Sciences Exposition in Stamford, CT
Monday, September 24, 2012 at 1:00 p.m. (ET)

Live audio webcasts and replays of these presentations will be available on the "Investors" section of the Company's website, [ www.syntapharma.com ].

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit [ www.syntapharma.com ].


Publication Contributing Sources